Cargando…

Benefits of pulmonary rehabilitation in patients with advanced lymphangioleiomyomatosis (LAM) compared with COPD – a retrospective analysis

ABSTRACT: Lymphangioleiomyomatosis (LAM) is a rare and progressive cystic lung disease with limited therapeutic options. We retrospectively analyzed the effects of a comprehensive 4-week inpatient pulmonary rehabilitation (PR) program in 58 patients with advanced LAM (FEV1: 45 ± 34%predicted, 6-min...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gloeckl, Rainer, Nell, Christoph, Schneeberger, Tessa, Jarosch, Inga, Boensch, Martina, Watz, Henrik, Wirtz, Hubert, Welte, Tobias, Kenn, Klaus, Koczulla, Andreas Rembert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507679/ https://www.ncbi.nlm.nih.gov/pubmed/32962746 http://dx.doi.org/10.1186/s13023-020-01540-3

Ejemplares similares

Improvements in functional and cognitive status following short-term pulmonary rehabilitation in COPD lung transplant recipients: a pilot study
por: Andrianopoulos, Vasileios, et al.
Publicado: (2019)

Whole-body vibration training versus conventional balance training in patients with severe COPD—a randomized, controlled trial
por: Gloeckl, Rainer, et al.
Publicado: (2021)

Benefits of pulmonary rehabilitation in COVID-19: a prospective observational cohort study
por: Gloeckl, Rainer, et al.
Publicado: (2021)

Acute effects of supplemental oxygen therapy using different nasal cannulas on walking capacity in patients with idiopathic pulmonary fibrosis: a randomised crossover trial
por: Schneeberger, Tessa, et al.
Publicado: (2020)

Rehabilitation in der Pneumologie
por: Leitl, Daniela, et al.
Publicado: (2021)

Automatic oxygen titration versus constant oxygen flow rates during walking in COPD: a randomised controlled, double-blind, crossover trial
por: Schneeberger, Tessa, et al.
Publicado: (2023)

Pulmonary rehabilitation in long COVID: more than just natural recovery!?
por: Gloeckl, Rainer, et al.
Publicado: (2021)

Rehabilitation bei Post-COVID-19-Patienten - individuell und zielgerichtet
por: Leitl, Daniela, et al.
Publicado: (2022)

Rehabilitation bei Lungenerkrankungen: Für wen und mit welchen Möglichkeiten?
por: Jarosch, Inga, et al.
Publicado: (2021)

Rehabilitation bei Post-COVID-19-Patienten - individuell und zielgerichtet*
por: Leitl, Daniela, et al.
Publicado: (2022)

High-intensity non-invasive ventilation during exercise-training versus without in people with very severe COPD and chronic hypercapnic respiratory failure: a randomised controlled trial
por: Schneeberger, Tessa, et al.
Publicado: (2023)

Impact of a smartphone application (KAIA COPD app) in combination with Activity Monitoring as a maintenance prOgram following PUlmonary Rehabilitation in COPD: the protocol for the AMOPUR Study, an international, multicenter, parallel group, randomized, controlled study
por: Spielmanns, Marc, et al.
Publicado: (2020)

Using a smartphone application maintains physical activity following pulmonary rehabilitation in patients with COPD: a randomised controlled trial
por: Spielmanns, Marc, et al.
Publicado: (2023)

Short-Term Effects of Comprehensive Pulmonary Rehabilitation and its Maintenance in Patients with Idiopathic Pulmonary Fibrosis: A Randomized Controlled Trial
por: Jarosch, Inga, et al.
Publicado: (2020)

Rehabilitation nach COVID-19-Erkrankung
por: Jarosch, Inga, et al.
Publicado: (2021)

Lymphangioleiomyomatosis (LAM)
Publicado: (2017)

Protocol for an observational study to identify potential predictors of an acute exacerbation in patients with chronic obstructive pulmonary disease (the PACE Study)
por: Kenn, Klaus, et al.
Publicado: (2021)

Relationship between body composition, exercise capacity and health-related quality of life in idiopathic pulmonary fibrosis
por: Machado, Felipe V C, et al.
Publicado: (2021)

Pregnancy after the diagnosis of lymphangioleiomyomatosis (LAM)
por: Shen, Lisha, et al.
Publicado: (2021)

Cardiopulmonary response during whole-body vibration training in patients with severe COPD
por: Gloeckl, Rainer, et al.
Publicado: (2017)

“Getting stuck with LAM”: patients perspectives on living with Lymphangioleiomyomatosis
por: Belkin, Amanda, et al.
Publicado: (2014)

LAM Cells as Potential Drivers of Senescence in Lymphangioleiomyomatosis Microenvironment
por: Bernardelli, Clara, et al.
Publicado: (2022)

Whole-Body Vibration Training During a Low Frequency Outpatient Exercise Training Program in Chronic Obstructive Pulmonary Disease Patients: A Randomized, Controlled Trial
por: Spielmanns, Marc, et al.
Publicado: (2017)

A randomized cross-over trial on the direct effects of oxygen supplementation therapy using different devices on cycle endurance in hypoxemic patients with Interstitial Lung Disease
por: Edvardsen, Anne, et al.
Publicado: (2018)

Benefits of whole body vibration training in patients hospitalised for COPD exacerbations - a randomized clinical trial
por: Greulich, Timm, et al.
Publicado: (2014)

Cognitive impairment in COPD: should cognitive evaluation be part of respiratory assessment?
por: Andrianopoulos, Vasileios, et al.
Publicado: (2017)

Pulmonary lymphangioleiomyomatosis (LAM): A literature overview and case report
por: Cong, Cung-Van, et al.
Publicado: (2022)

Feasibility and safety of whole-body vibration therapy in intensive care patients
por: Alter, Peter, et al.
Publicado: (2017)

Therapeutic options for lymphangioleiomyomatosis (LAM): where we are and where we are going
por: Taveira-DaSilva, Angelo M, et al.
Publicado: (2009)

Development of ATAQ-LAM: a tool to assess quality of life in Lymphangioleiomyomatosis
por: Walker, Tarik D., et al.
Publicado: (2015)

Validity and Usability of Physical Activity Monitoring in Patients with Chronic Obstructive Pulmonary Disease (COPD)
por: Boeselt, Tobias, et al.
Publicado: (2016)

A randomized clinical trial to assess the influence of a three months training program (Gym-based individualized vs. Calisthenics-based non-invidualized) in COPD-patients
por: Greulich, Timm, et al.
Publicado: (2014)

Mutation spectrums of TSC1 and TSC2 in Chinese women with lymphangioleiomyomatosis (LAM)
por: Liu, Jie, et al.
Publicado: (2019)

Estradiol Augments the Production and Actions of Polymorphonuclear Cells to Promote Lymphangioleiomyomatosis (LAM) Progression
por: Minor, Briaunna M N, et al.
Publicado: (2021)

Longitudinal stability of blood eosinophil count strata in the COPD COSYCONET cohort
por: Greulich, Timm, et al.
Publicado: (2018)

Pseudoneutropenia in lymphangioleiomyomatosis (LAM) patients receiving sirolimus: evaluation in a 100 patient cohort
por: Gopalakrishnan, Vissagan, et al.
Publicado: (2018)

A Case of Lymphangioleiomyomatosis (LAM) of the Lung in a Patient with a History of Breast Cancer
por: Koc-Günel, Sinem, et al.
Publicado: (2019)

Correction: Mutation spectrums of TSC1 and TSC2 in Chinese women with lymphangioleiomyomatosis (LAM)
por: Liu, Jie, et al.
Publicado: (2020)

RF19 | PSUN351 Glycoprotein-NMB (GPNMB) is Pro-Tumorigenic in Lymphangioleiomyomatosis (LAM)
por: Gibbons, Erin, et al.
Publicado: (2022)

The Epidemiology and Clinical Features of Lymphangioleiomyomatosis (LAM): A Descriptive Study of 33 Case Reports
por: Shah, Jaini M, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ltf4g66uauu035eqmtvok5ddib